Hiroshi Nagai

9PUBLICATIONS
10CO-AUTHORS
Catalysis and mechanisms of reactionsAllergyMolecular medicineTumour immunologyNatural products and bioactive compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 13, 2021
Koebner phenomenon seen in a case of drug-induced granular C3 dermatosis.

M Ohata, T Fukumoto, T Hashimoto

|Oct 31, 2020
Topical imiquimod-induced lichenoid drug reaction successfully treated with tacrolimus ointment.

Keiko Furuoka, Takeshi Fukumoto, Hiroshi Nagai

|Oct 12, 2020
Successful treatment of pityriasis rubra pilaris with guselkumab: Serum CCL20 as a potential marker for the disease activity.

Hiroshi Nagai, Haruki Jimbo, Shoko Matsuura

|Nov 02, 2019
Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-α and interferon-γ in Fas-mediated melanocyte apoptosis.

Haruki Jimbo, Hiroshi Nagai, Susumu Fujiwara

|Oct 11, 2019
Image Gallery: Antihelix red-violaceous macules in juvenile dermatomyositis associated with antimelanoma differentiation-associated protein 5 antibody.

H Nagai, C Nishigori

|Jan 18, 2018
Allergic contact dermatitis caused by Olanedine® (olanexidine gluconate), a new antiseptic.

Hiroshi Nagai, Hitoshi Fukuda

Pageof 2

Frequent Collaborators

2 joint publications

Takeshi Fukumoto

1 joint publications

T Hashimoto

1 joint publications

H Jimbo

1 joint publications

Nagaraj Kerur